The Canadian Cancer Society (CCS) is excited to launch the CCS Emerging Scholar Award program, aimed at establishing and advancing promising early career scientists and clinician scientists from across Canada with a focused commitment to undertaking cancer research. Through the CCS Emerging Scholar Award program, early career investigators will develop their cancer research programs in Canada and pursue important scientific advances of the highest quality and potential for impact. By making a significant investment in the advancement of our nation’s emerging scholars, CCS aims to the strengthen the future of the Canadian cancer research ecosystem.
LOI due: February 5, 2020
LOI results: early April 2020
Full applications due: June 30, 2020
Funding results: December 2020
Funding start date: January 1, 2021
At the time of the award start date (January 1, 2021), applicants:
- must be scientists or clinician scientists who hold a full-time appointment at an eligible Canadian research institution.
- must be within 5 years* from the start of their first independent academic appointment (minimum assistant professor level, or equivalent).
- must have (a) firm faculty appointment(s).
- must not be current recipients of awards aimed at advancing the career development of early career investigators (including CRCs).
CCS is committed to supporting all areas and disciplines of cancer research and building capacity across Canada. Applications from the four pillars of health research (ie. biomedical; clinical; health services; and social, cultural, environmental and population health) are encouraged, and geographic and gender diversity will be strongly considered during the evaluation process.
Successful applications must fall within the fundable range for CCS awards (>3.5).